Replaces Prod. #: BML-P418
Reversible, aldehyde inhibitor of caspase-3 and related cysteine proteases. Exhibits high selectivity for caspase-3 over -1, -4, -6, and -7. Sequence is based on baculovirus p35 protein inhibitor site of cleavage. Together with the caspase-6 inhibitor Ac-VEID-CHO (Prod. No. ALX-260-062) this inhibitor has been used to dissect the pathway of caspase activation in Fas-stimulated Jurkat cells.
Product Specification
| Alternative Name: | Caspase-3 inhibitor (aldehyde) |
| |
| Formula: | C20H31N5O10S |
| |
| MW: | 533.6 |
| |
| Purity: | ≥96% (HPLC) |
| |
| Appearance: | White powder. |
| |
| Sequence: | Ac-Asp-Met-Gln-Asp-CHO |
| |
| Formulation: | Lyophilized. |
| |
| Peptide Content: | 70-90%. |
| |
| Solubility: | Soluble in DMSO or distilled water. |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Stock solutions should be divided into aliquots and stored at -20°C. |
| |
| Handling: | Keep cool and dry. |
| |
Product Literature References
Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis: H. Hirata, et al.; J. Exp. Med.
187, 587 (1998),
Abstract;
Substrate specificities of caspase family proteases: R.V. Talanian et al.; J. Biol. Chem.
272, 9677 (1997),
Abstract;
Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease: J. Bertin et al.; J. Virol.
70, 6251 (1996),
Abstract;